Delirium due to a drug-drug interaction of lithium and an NSAID.
Faaij
R A
RA
Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Ziere
G
G
Zietse
R
R
Van der Cammen
T J M
TJ
D000058:Accidental Falls; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage; D003693:Delirium / Q000097:blood / Q000139:chemically induced*; D003865:Major Depressive Disorder / Q000188:drug therapy; D004008:Diclofenac / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D005440:Fluid Therapy; D016666:Fluvoxamine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D004008:Diclofenac; D016651:Lithium Carbonate; D006220:Haloperidol; D016666:Fluvoxamine